The effect of the milk drink on immunity index for healthy adults
- Conditions
- Healthy subjects
- Registration Number
- JPRN-UMIN000049778
- Lead Sponsor
- CPCC Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 100
Not provided
subjects -- 1. proved positive for COVID-19 before the pre-test, hepatitis B, hepatitis C, syphilis, or acquired immune deficiency syndrome at the pre-test, 2. with positive for COVID-19 within the past four weeks before the final examination, 3. planning to be vaccinated against COVID-19 and influenza, during this test, 4. having any symptoms (e.g., chronic rhinitis, asthma), with a difficulty in distinguishing from upper respiratory tract infection, 5. with any difficulty in giving up taking pollinosis medicines (except eye and nasal drops) during this test, 6. with abdominal symptoms by ingesting dairy products, 7. who constantly intake fermented dairy products and/or lactic acid bacteria preparation (e.g., yogurt, lactic fermenting beverage), 8. who take steadily (over twice a week) in affecting health-specific/functional/supplementary/health foods, 9. who take steadily (over twice a week) in affecting medicines (e.g., antibiotic/gut/laxative regulation), 10. with excessive alcohol intake, 11. with heavy heavy smoking (more than 21per day), 12. with extremely irregular eating habits / life rhythm (e.g., midnight work), 13. who have previous and/or current medical history of serious disease, 14. with pregnant, possibly pregnant, or lactating, 15. who have previous medical history of drug and/or food, allergy, especially for milk, 16. being under other clinical tests, or partook in those within the past four weeks before this test, or will join those after the consent, 17. who donated over 0.2L blood and/or blood components within the last one month. 18. who donated over his 0.4L whole blood within the last three month, 19. who donated over her 0.4L whole blood within the last four month, 20. being collected in total of his blood (1.2 L) within the past 12 months and in this test, 21. being collected in total of her blood (0.8 L) within the past 12 months and in this test, 22. Others who have been determined ineligible by principal investigator --.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Immunity index
- Secondary Outcome Measures
Name Time Method